difference between glp 1 and sglt2 Prescribe inhibitors, GLP-1 receptor agonists 'as early as possible' for CV benefit Comparing cardiovascular benefits between GLP-1

Overstimulation of growth pathways may cause enlargement of bones in the hands, feet, or jaw, soft tissue thickening, and in severe cases, organomegaly (enlargement of organs)

Published online May 15, 2025

GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly

Zhang HQ, Chen SY, Wang AS, Yao AJ, Fu JF, Zhao JS, Chen F, Zou ZQ, Zhang XH, Shan YJ, Bao YP (2016) Sulforaphane induces adipocyte browning and promotes glucose and lipid utilization